News

Postpartum drug is a game changer, but can women afford it?

Several companies are recalling products due to contamination from substances such as carcinogens and glass-here’s what you should know.

The ONC and CMS medical information transparency rule for patients, providers, and insurers may be the biggest change in healthcare system operations since the ACA. Here’s what to expect.

Typical idea-creation meetings are dull and don’t actually result in actionable items. Here’s how you can change that.

The answers lie in innovation, collaboration, and a national approach.

How one primary care practice used a team-based approach to reduce readmission rates for COPD patients.

A successful organization is a productive one, but a lot can stand in your way. Here’s how to get around the barriers to create a more efficient working environment.

Access to broad snapshot of the patient’s pharmacy and medical data can help spot and address drug misuse.

Nasal spray offers promise for treatment-resistant depression, but proceed with caution. 

Experts share 16 tips for acquiring top talent for a first-class workforce.

New report shows that some premiums and deductibles were lower for 2019-and that members are using new tools to help them save.

How FDA Chief Gottlieb’s resignation could impact the pharma industry.

Innovation doesn’t happen by accident-here’s how healthcare organizations around the country are bringing their operations and technologies into the future.

Patient identification is in desperate need of an overhaul-and biometrics could be the answer.

No longer a pipe-dream of fringe policy makers, Medicare for All is gaining serious support-and criticism. Here’s what you need to know about the current conversation.

How are employers coping with rising healthcare costs?

Last year brought a variety of new treatments-and complications-for patients and payers. These five areas that defined 2018 will continue to define the future.

It’s obvious that the healthcare system is due for some major innovations, but are we looking for them in the right places?

Each hospital and health system-and insurer-has unique circumstances, but there are several common approaches that are likely to help curb the growth in drug costs.

The recalls of a widely used hypertension blood drug due to carcinogenic impurities are expanding.

The technology is improving rapidly, becoming not only more accessible but much, much cheaper.

Elodia Mercier, a 34-year nursing veteran, sets the tone for the way patients should be treated.

The latest in RA therapies, and what you can expect from the pipeline.